Manufacturer record

Gufic Biosciences Limited N.H.No. 08 Kabilpore: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Gufic Biosciences Limited N.H.No. 08 Kabilpore (Gujarat) were declared Not of Standard Quality between October 2025 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to Gufic Biosciences Limited N.H.No. 08 Kabilpore in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Oct 2025 to Dec 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2025
2
Products affected
Other
Most common failure
Dec 2025
Latest alert

Flagged batches per year

2025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
LEVTARY - 500 AA250585AMfg 2025-07 · Exp 2027-06 The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Free drugOther RDTL, ChandigarhCDSCO lab Dec 2025
Liposomal Amphotericin B Injection 50 mg (Gufisome 50 mg/vial) AA241096BMfg 2024-12 · Exp 2026-11 The sample does not conform to Manufacturer specification with respect to Clarity of solution, pH, reconstitution time, Particulate Matter, Free Drug and Assay of amphotericin B.Assay CDL, KolkataCDSCO lab Oct 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.